Fronto-caudate and callosal microstructural alterations: unveiling multimodal MRI biomarkers in early Parkinson's

Angela Bernabéu-Sanz1,2, Sandra Morales3, Valery Naranjo3

  • 1Magnetic Resonance Department, Inscanner SL, Calle San Pedro Poveda 10, Alicante, CP 03010, Spain.

PubMed
Abstract

Insights

Early Parkinson's disease (PD) shows brain structure changes linked to cognitive and motor symptoms. Fronto-caudate and interhemispheric pathway degeneration are identified as potential biomarkers for disease progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Brain Anatomy

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
  • Early-stage PD involves subtle cognitive and motor deficits that may be linked to underlying brain structural changes.
  • Understanding these early changes is crucial for predicting disease progression and cognitive vulnerability.

Purpose of the Study:

  • To investigate gray and white matter alterations in early-stage PD.
  • To examine the association between these structural changes and motor/cognitive symptoms.
  • To identify potential imaging biomarkers for early PD.

Main Methods:

  • Multimodal MRI (Voxel-Based Morphometry and Diffusion Tensor Imaging) was used.
  • Thirty-one early-stage PD patients and 30 healthy controls were included.
  • Comprehensive clinical and neuropsychological assessments were performed.

Main Results:

  • PD patients exhibited memory and processing speed deficits.
  • VBM revealed bilateral caudate atrophy.
  • DTI showed widespread white matter microstructural alterations, particularly in the corpus callosum and association tracts, correlating with disease duration and motor scores.
  • Reduced fronto-caudate and caudate-cingulum streamline density correlated with cognitive and motor impairments.

Conclusions:

  • Early-stage PD is characterized by functionally relevant degeneration of fronto-caudate and interhemispheric pathways.
  • These structural changes are associated with specific cognitive and motor impairments.
  • The identified structural alterations serve as candidate imaging biomarkers for early PD progression and cognitive vulnerability.